Feasibility and Impact of "ABCs of Diabetes" Self-Management Education Program at an Urban Public Library
Feasibility and Impact of of "ABC's of Diabetes" Self Management Education (DSME) Program for African Americans at an Urban Public Library on A1C, Lipid Lowering Agent Prescriptions and Emergency Department Visits
1 other identifier
interventional
360
1 country
1
Brief Summary
A concise diabetes self-management education (DSME) program on the "ABCs of Diabetes" will be placed in an urban public library to assess the feasibility of using this community setting for the delivery of health care education in an urban African American population. Impact on knowledge of, prescriptions for, and control of blood sugar (A1C), blood pressure (BP) and LDL cholesterol (LDL-C)before and after participation in the program will be assessed. We will also examine the frequency of emergency department (ED) visits and hospitalizations for uncontrolled diabetes at 6 months post-DSME intervention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable diabetes
Started Jan 2003
Typical duration for not_applicable diabetes
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2003
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2005
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2005
CompletedFirst Submitted
Initial submission to the registry
January 12, 2009
CompletedFirst Posted
Study publicly available on registry
January 14, 2009
CompletedAugust 25, 2020
August 1, 2020
2 years
January 12, 2009
August 21, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Improvement in the percent of subjects correctly identifying guideline-recommended treatment targets for the "ABC's of Diabetes", where A = A1C < 7%; B = BP <130/80mmHg and; and C = LDL-C < 100mg/dl.
6 months following program completion
Secondary Outcomes (4)
increase the percentage of subjects taking medications for A1C, BP and LDL-C management and aspirin;
6 months following DSME program completion
increase scores on the diabetes self-efficacy scale (DES);
6 months following DSME program completion
increase percentage of patients with A1C, BP and LDL-C at recommended targets;
6 months following program completion
Decrease the percentage of participants with self-reported ED visits and hospitalizations for severe hypoglycemia and hyperglycemia.
6 months following DSME program completion
Study Arms (1)
Diabetes Self-Management Education
OTHEREducation intervention with historic self-controls.
Interventions
DSME intervention consisting of two interactive 2-1/2 hour classes taught by a diabetes educator focusing on the "ABCs of diabetes" and training in how to talk to your doctor.
Eligibility Criteria
You may qualify if:
- Diagnosis of Diabetes Mellitus, type 1 or type 2 for at least one month prior to taking the first educational class.
- years old or older.
- Females and Males
- All ethnic groups.
- Must be able to read and speak English.
- Must be willing to sign informed consent to participate in the research component of the program.
- Plan on living in the District of Columbia for the next 6 to 8 months.
- Willing to attend 2 core interactive education sessions within a 6-week period.
- Willing to have a fingerstick performed to obtain blood for A1C and cholesterol determinations prior to and 6 months after completion of the educational sessions.
- Willing to attend both a pre- and a post-study outcomes data collection visit, each of which will last approximately 1 - 1 ½ hours.
- Ability and willingness to adhere to all study requirements.
- Participant must have active health insurance coverage or self pay and have regular visits to their primary care physician. Interested parties who do not have health insurance will be referred to DHHS for assistance in applying for Medicare or Medicaid when applicable.
- Have access to telephone in residence to receive reminder calls for up upcoming visits.
You may not qualify if:
- Pregnancy.
- Non-English speaking.
- Untreated mental illness.
- History of substance abuse or alcohol abuse in the past 12 months.
- Individuals participating in a drug research study.
- Presence of concomitant condition or circumstances which, in the opinion of the investigator, could interfere with participation in the study, glycemic control or interpretation of the data collected. (e.g. active malignance; HIV/AIDS)
- Chronic concomitant use of oral steroids.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Medstar Health Research Institutelead
- Medstar Diabetes Institute;collaborator
- American Diabetes Associationcollaborator
- Bayercollaborator
- CareFirst BlueCross Blue Shield;collaborator
- District of Columbia, Department of Health Block Grants Program;collaborator
- Charles and Mary Latham Trust Fund;collaborator
- Eli Lilly and Companycollaborator
- Hewlett-Packardcollaborator
- Meltzer Entities;collaborator
- NBC Washingtoncollaborator
- Novo Nordisk A/Scollaborator
- Aventis Pharmaceuticalscollaborator
- Takeda Pharmaceuticals North America, Inc.collaborator
- Pfizercollaborator
Study Sites (1)
Washington Hospital Center
Washington D.C., District of Columbia, 20010, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Michelle F. Magee, MD, LRCPSI
Medstar Health Research Institute
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Medicine, Georgetown University School of Medicine
Study Record Dates
First Submitted
January 12, 2009
First Posted
January 14, 2009
Study Start
January 1, 2003
Primary Completion
January 1, 2005
Study Completion
July 1, 2005
Last Updated
August 25, 2020
Record last verified: 2020-08